Dr Sherrie Kelly is an infectious disease modeller specialising in applied health economics. She has over 15 years of experience working with countries across all income levels and global regions, as well as with a wide range of national and international organisations.
Dr Kelly has a background in epidemiology and global health with focus on HIV, TB, and maternal-child health. Dr Kelly leads the Burnet Institute’s Optima group on HIV, TB, and malaria modeling applications and research, as well as facilitates Optima training workshops and country missions.
Prior to joining the Optima team, Dr Kelly worked with UNAIDS and the Public Health Agency of Canada, having experience in infectious disease emergency response and basic laboratory research.
Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies.
GBD 2015 and HIV estimates from the Optima model.
Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
HIV Cascade Monitoring and Simple Modeling Reveal Potential for Reductions in HIV Incidence.
Factors Associated With Increased Rates of Caesarean Section in Women of Advanced Maternal Age.
HIV Mathematical Modelling to Support Swaziland's Development of its HIV Investment Case.
Examining caesarean section rates in Canada using the Robson classification system.
Measuring quality in maternal-newborn care: developing a clinical dashboard.
Estimates of HIV burden in emergencies.
HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.
N-Acetylsphingosine stimulates phosphatidylglycerolphosphate synthase activity in H9c2 cardiac cells.
On the mechanism of the phospholipase C-mediated attenuation of cardiolipin biosynthesis in H9c2 cardiac myoblast cells.